| Target Price | $36.72 |
| Price | $33.58 |
| Potential |
9.35%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Twist Bioscience Corp. 2026 .
The average Twist Bioscience Corp. target price is $36.72.
This is
9.35%
register free of charge
$60.03
78.76%
register free of charge
$32.32
3.75%
register free of charge
|
|
| A rating was issued by 17 analysts: 14 Analysts recommend Twist Bioscience Corp. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Twist Bioscience Corp. stock has an average upside potential 2026 of
9.35%
register free of charge
|
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 376.57 | 433.77 |
| 20.32% | 15.19% | |
| EBITDA Margin | -29.59% | -8.32% |
| 35.91% | 71.88% | |
| Net Margin | -20.63% | -21.50% |
| 69.07% | 4.24% |
13 Analysts have issued a sales forecast Twist Bioscience Corp. 2026 . The average Twist Bioscience Corp. sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Twist Bioscience Corp. EBITDA forecast 2026. The average Twist Bioscience Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Twist Bioscience Corp. Analysts have issued a net profit forecast 2026. The average Twist Bioscience Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.30 | -1.54 |
| 63.89% | 18.46% | |
| P/E | negative | |
| EV/Sales | 4.20 |
13 Analysts have issued a Twist Bioscience Corp. forecast for earnings per share. The average Twist Bioscience Corp. EPS is
This results in the following potential growth metrics and future valuations:
Twist Bioscience Corp....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 17 2025 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 07 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 02 2025 |
| Baird |
Locked
➜
Locked
|
Locked | May 06 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | May 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 17 2025 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 07 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 02 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
May 06 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
May 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


